Patents for A61P 33 - Antiparasitic agents (21,787) |
---|
02/01/2007 | US20070025994 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
02/01/2007 | CA2616768A1 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents |
01/31/2007 | EP1747020A2 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists |
01/31/2007 | EP1747019A2 Camptothecin derivatives conjugated in position 20 with integrin antagonists |
01/31/2007 | EP1747002A2 New apiary veterinary composition |
01/31/2007 | CN1905897A Antagonist anti-CD40 monoclonal antibodies and methods for their use |
01/31/2007 | CN1903351A Funing gel prepn. and its prepn. method |
01/31/2007 | CN1297554C Amido ether substituted imidazoquinolines |
01/31/2007 | CN1297316C Mutant forms of cholera holotoxin as adjuvant |
01/30/2007 | US7169899 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents |
01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
01/30/2007 | US7169398 Equine protozoal myeloencephalitis vaccine |
01/30/2007 | CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
01/25/2007 | WO2007010965A1 Azaindole derivative having pgd2 receptor antagonistic activity |
01/25/2007 | WO2007009201A2 Process to obtain synthetic and semi-synthetic lignan derivatives, their antiparasitic activities and corresponding pharmaceutical formulations, including the therapeutic method using said lignan for the treatment of parasitosis |
01/25/2007 | US20070021596 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata, tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis |
01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
01/25/2007 | US20070021409 10th Carbon substitution with nitrogen heterocyclic group, halogen, or cycloalkyl or aryl group for use as stable agents against Plasmodium falciparum, Neospora caninum and Eimeria tenella which cause malaria, neosporosis and coccidiosis |
01/25/2007 | US20070021390 thiazole, oxazole derivatives useful for treating neurodegenerative disorders or pain |
01/25/2007 | CA2615738A1 Bifunctional protein anchors |
01/24/2007 | EP1746159A2 Immunostimulatory nucleic acid molecules |
01/24/2007 | EP1746103A1 Bifunctional protein anchors |
01/24/2007 | EP1745778A2 Diaminoalcohols as therapeutic compounds |
01/24/2007 | EP1745777A1 Amido-aminoalcohols as therapeutic compounds |
01/24/2007 | EP1744781A1 Treatment of infectious diseases |
01/24/2007 | EP1334970B1 Novel ft-0554a substances and process for the preparation thereof |
01/24/2007 | EP1262482B1 Novel trioxa tricyclic compounds having antimalarial activity |
01/24/2007 | EP1180028B1 Il-8 receptor antagonists |
01/24/2007 | EP1032416B1 Neospora vaccines |
01/24/2007 | EP1028722B1 Pharmaceutically active composition containing artemisinine and/or a derivative of artemisinine |
01/24/2007 | CN1902199A 4-amino-quinoline ouinolizidinyl-and quinolizidinylalkyl-derivatives with antimalarial activity |
01/24/2007 | CN1901896A Use of selected amino acid-zinc complexes as anti-malarials |
01/24/2007 | CN1901892A Treating infectious diseases using ice inhibitors |
01/24/2007 | CN1900080A Inhibitors of cruzipain and other cysteine proteases |
01/24/2007 | CN1900064A Synthesis and application of 6-(2-methoxy phenoxy)-1,4-dihydrogen-4-oxo-3-ethyl quinolinecarboxylate |
01/24/2007 | CN1899412A Suppository for treating gynecopathy and its preparing method |
01/24/2007 | CN1899301A Anti-parasite medicine for aquatic cultication |
01/24/2007 | CN1899283A Quality control method for medicinal composition containing artemisine |
01/24/2007 | CN1296357C Heteroaryl-substituted aminocyclohexane derivatives |
01/23/2007 | US7166623 Pain and inflammation |
01/23/2007 | US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES |
01/23/2007 | US7166597 Antiinflammatory agents; autoimmune disease treatments; pyrazolo(1,5-a)pyridine derivatives |
01/23/2007 | US7166297 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen |
01/18/2007 | WO2007006197A1 Use of levo-ornidazole for preparing antiparasitic infection drug |
01/18/2007 | WO2006073748A3 Antibodies against antigen presenting cells and uses thereof |
01/18/2007 | US20070015772 Nucleoside metabolism inhibitors |
01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
01/18/2007 | US20070015258 Alpha-beta C4BP -type recombinant heteromultimeric proteins |
01/17/2007 | EP1743944A1 Novel method of screening |
01/17/2007 | EP1383751B1 Novel azoles having an insecticidal action |
01/17/2007 | EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
01/17/2007 | EP1272160B1 Lipid-based drug delivery systems for topical application |
01/17/2007 | EP1223977B1 Modified plant viruses and methods of use thereof |
01/17/2007 | CN1895369A Domestic Chinese-herb insect-repellent growth |
01/17/2007 | CN1895344A Chinese-medicinal preparation for clearing heat, drying dampness and killing worms and its making method |
01/17/2007 | CN1895342A Fowl anticoccidial medicinal composition and its preparation |
01/17/2007 | CN1295240C Intermediate and process for preparation of 4''-substituted-9A-deoxy-9A-aza-erythromycin derivative |
01/17/2007 | CN1295213C Fluorinated cycloalkyl-derivatized benzoylguanidines and their uses as medicament |
01/17/2007 | CN1294952C Traditional Chinese medicine compound preparation for preventing and treating coccidiosis |
01/11/2007 | WO2007002988A1 Formulation of microbial pesticides |
01/11/2007 | US20070010575 Intracorporeal medicaments for photodynamic treatment of disease |
01/11/2007 | US20070009994 Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen |
01/11/2007 | US20070009487 Minimal promoters and uses thereof |
01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
01/10/2007 | EP1313491B1 Bioactive fraction of eurycoma longifolia |
01/10/2007 | EP1232180B1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
01/10/2007 | EP0915705B1 Ionic polymers as anti-infective agents |
01/10/2007 | CN1894259A Rifamycin analogs and uses thereof |
01/10/2007 | CN1894244A Aryl ether substituted imidazoquinolines |
01/10/2007 | CN1893966A Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
01/10/2007 | CN1293921C Long-term effective injection containing ethylcellulose and fatty acid ester |
01/09/2007 | CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
01/04/2007 | WO2006087642A3 9a-carbamoyl and thiocarbamoyl azalides with antimalarial activity |
01/04/2007 | WO2006085228A3 9a-carbamoyl-y-aminopropyl and 9a-thiocarbamoyl-y-aminopropyl-azalides with antimalarial activity |
01/04/2007 | WO2006075256A3 9a-carbamoyl-ϝ-aminopropyl- and 9a-thiocarbamoyl-ϝ-aminopropyl-azalides with antimalarial activity |
01/04/2007 | US20070003987 Screening method for substance binding to merozoite surface protein-1/42 |
01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
01/03/2007 | EP1738647A1 Process for producing mallotus philippensis colorant composition and the composition |
01/03/2007 | EP1737876A1 Avermectin and avermectin monosaccharide substituted in the 4"-and 4'-position respectively |
01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
01/03/2007 | CN1887907A Recombinant Plasmodium falciparum 175kD erythrocyte conjugated antigen functional region protein and its prepn and use |
01/03/2007 | CN1293192C Immunoregulation polynucleotide and using method thereof |
01/03/2007 | CN1293047C Aminoacetonitriles derivant for controlling parasite |
01/02/2007 | US7157457 Compounds useful in the treatment of inflammatory diseases |
01/02/2007 | US7157449 Use of an inhibitor of CTP synthetase, such as a glutamine analogue, and a substance use of an inhibitor of CTP synthetase, such as a glutamine analogue, and a substance capable of suppressing toxic effects in the manufacture of |
01/02/2007 | US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
12/28/2006 | WO2006138195A1 Macrocyclic heterocyclic aspartyl protease inhibitors |
12/28/2006 | WO2006137258A1 Pharmaceutical composition comprising azarhodacyanine compound as active ingredient |
12/28/2006 | WO2006136822A1 Inhibitor compounds |
12/28/2006 | WO2006077429A8 Anthelmintic composition |
12/28/2006 | US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
12/28/2006 | US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
12/28/2006 | US20060292170 Vaccine Composition Against Malaria |
12/28/2006 | CA2610828A1 Heterocyclic aspartyl protease inhibitors, preparation and use thereof |
12/28/2006 | CA2609562A1 Macrocyclic heterocyclic aspartyl protease inhibitors |
12/27/2006 | EP1736161A2 Use of an arsenic compound for the manufacture of a medicament for the treatment of arsenic susceptible blast-like cell related diseases |
12/27/2006 | EP1735284A1 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides |
12/27/2006 | EP1734954A1 Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use |